270 related articles for article (PubMed ID: 11709780)
1. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
3. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
Jacobson MA; Bredt BM
J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
[No Abstract] [Full Text] [Related]
4. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
5. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
7. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
Jacobson MA; Schrier R; McCune JM; Torriani FJ; Holland GN; O'Donnell JJ; Freeman WR; Bredt BM
J Infect Dis; 2001 May; 183(9):1399-404. PubMed ID: 11294673
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
10. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Weinberg A; Wohl DA; Barrett RJ; van der Horst C
J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
13. Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
Furco A; Carmagnat M; Chevret S; Garin YJ; Pavie J; De Castro N; Charron D; Derouin F; Rabian C; Molina JM
AIDS; 2008 Oct; 22(16):2087-96. PubMed ID: 18832872
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
Lilleri D; Piccinini G; Genini E; Comolli G; Chiesa A; Tordato F; Sotgiu G; Parisi A; Baldanti F; Revello MG; Gerna G
J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
Berenguer J; González J; Pulido F; Padilla B; Casado JL; Rubio R; Arribas JR;
Clin Infect Dis; 2002 Feb; 34(3):394-7. PubMed ID: 11753827
[TBL] [Abstract][Full Text] [Related]
17. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.
Stone SF; Price P; Tay-Kearney ML; French MA
J Infect Dis; 2002 Jun; 185(12):1813-7. PubMed ID: 12085331
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
Banker AS; Patel A
Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
